AVDL
Price
$21.49
Change
-$0.01 (-0.05%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
2.11B
53 days until earnings call
Intraday BUY SELL Signals
LIEN
Price
$10.85
Change
+$0.06 (+0.56%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
246.23M
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVDL vs LIEN

Header iconAVDL vs LIEN Comparison
Open Charts AVDL vs LIENBanner chart's image
Avadel Pharmaceuticals
Price$21.49
Change-$0.01 (-0.05%)
Volume$29.74K
Capitalization2.11B
Chicago Atlantic BDC
Price$10.85
Change+$0.06 (+0.56%)
Volume$858
Capitalization246.23M
AVDL vs LIEN Comparison Chart in %
View a ticker or compare two or three
VS
AVDL vs. LIEN commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVDL is a Hold and LIEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (AVDL: $21.50 vs. LIEN: $10.79)
Brand notoriety: AVDL: Notable vs. LIEN: Not notable
AVDL represents the Pharmaceuticals: Generic, while LIEN is part of the Investment Managers industry
Current volume relative to the 65-day Moving Average: AVDL: 86% vs. LIEN: 100%
Market capitalization -- AVDL: $2.11B vs. LIEN: $246.23M
AVDL [@Pharmaceuticals: Generic] is valued at $2.11B. LIEN’s [@Investment Managers] market capitalization is $246.23M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.17B to $0. The market cap for tickers in the [@Investment Managers] industry ranges from $169.4B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.59B. The average market capitalization across the [@Investment Managers] industry is $7.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVDL’s FA Score shows that 0 FA rating(s) are green whileLIEN’s FA Score has 1 green FA rating(s).

  • AVDL’s FA Score: 0 green, 5 red.
  • LIEN’s FA Score: 1 green, 4 red.
According to our system of comparison, AVDL is a better buy in the long-term than LIEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVDL’s TA Score shows that 2 TA indicator(s) are bullish while LIEN’s TA Score has 4 bullish TA indicator(s).

  • AVDL’s TA Score: 2 bullish, 3 bearish.
  • LIEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LIEN is a better buy in the short-term than AVDL.

Price Growth

AVDL (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LIEN (@Investment Managers) price change was +4.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.08%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was +19.08%.

The average weekly price growth across all stocks in the @Investment Managers industry was +0.83%. For the same industry, the average monthly price growth was +4.66%, and the average quarterly price growth was +7.68%.

Reported Earning Dates

AVDL is expected to report earnings on Mar 09, 2026.

LIEN is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Investment Managers (+0.83% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVDL($2.11B) has a higher market cap than LIEN($246M). LIEN YTD gains are higher at: 4.453 vs. AVDL (-0.232). AVDL has more cash in the bank: 91.6M vs. LIEN (5.4K). AVDL has less debt than LIEN: AVDL (2.55M) vs LIEN (11M). AVDL has higher revenues than LIEN: AVDL (249M) vs LIEN (39.9M).
AVDLLIENAVDL / LIEN
Capitalization2.11B246M858%
EBITDA10.1MN/A-
Gain YTD-0.2324.453-5%
P/E RatioN/A6.13-
Revenue249M39.9M624%
Total Cash91.6M5.4K1,696,296%
Total Debt2.55M11M23%
FUNDAMENTALS RATINGS
AVDL: Fundamental Ratings
AVDL
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
41
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVDLLIEN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
54%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 21 days ago
84%
Bullish Trend 4 days ago
51%
Declines
ODDS (%)
Bearish Trend 11 days ago
81%
Bearish Trend 16 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AVDL
Daily Signal:
Gain/Loss:
LIEN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICISX14.700.06
+0.41%
VY® Columbia Small Cap Value II I
FLCPX27.71N/A
N/A
Fidelity SAI US Large Cap Index
BABDX12.08-0.02
-0.17%
BlackRock Global Dividend Inv A
DGEYX26.53-0.05
-0.19%
BNY Mellon Global Emerging Mkts - Y
NGUAX29.61-0.35
-1.17%
Neuberger Large Cap Growth Inv

AVDL and

Correlation & Price change

A.I.dvisor tells us that AVDL and RMTI have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVDL and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVDL
1D Price
Change %
AVDL100%
+0.09%
RMTI - AVDL
33%
Poorly correlated
+0.75%
RDY - AVDL
28%
Poorly correlated
+0.61%
COLL - AVDL
27%
Poorly correlated
-1.50%
AMLX - AVDL
27%
Poorly correlated
+11.67%
ELAN - AVDL
26%
Poorly correlated
-0.04%
More

LIEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIEN has been loosely correlated with TXMD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LIEN jumps, then TXMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIEN
1D Price
Change %
LIEN100%
+3.06%
TXMD - LIEN
36%
Loosely correlated
+1.90%
AVDL - LIEN
24%
Poorly correlated
+0.09%
SHPH - LIEN
21%
Poorly correlated
+6.29%
OXLCP - LIEN
11%
Poorly correlated
+0.11%
AKAN - LIEN
9%
Poorly correlated
-17.77%
More